EIDOS THERAPEUTICS, INC. Share-based Payment Arrangement, Expense
EIDOS THERAPEUTICS, INC. reported Share-based Payment Arrangement, Expense of $3.44 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2020-10-29
- EIDOS THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2020-09-30 was $3.44M, a 115.67% increase year-over-year.
- EIDOS THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2020-06-30 was $2.72M, a 133.10% increase year-over-year.
- EIDOS THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2020-03-31 was $1.93M, a 99.90% increase year-over-year.
- EIDOS THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2019-12-31 was $1.65M, a 99.76% increase year-over-year.
- EIDOS THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2019 was $5.37M, a 112.71% increase from fiscal 2018.
- EIDOS THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2018 was $2.53M, a 120.03% increase from fiscal 2017.
- EIDOS THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2017 was $1.15M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2020-09-30 | $3.44M 10-Q · filed 2020-10-29 | $6.16M derived: sum of 2 quarters · filed 2020-10-29 | $8.09M 10-Q · filed 2020-10-29 | $9.73M derived: sum of 4 quarters · filed 2020-10-29 | ||
| 2020-06-30 | $2.72M 10-Q · filed 2020-08-06 | $4.64M 10-Q · filed 2020-08-06 | $6.29M derived: sum of 3 quarters · filed 2020-08-06 | $7.89M derived: sum of 4 quarters · filed 2020-10-29 | ||
| 2020-03-31 | $1.93M 10-Q · filed 2020-05-08 | $3.58M derived: sum of 2 quarters · filed 2020-05-08 | $5.17M derived: sum of 3 quarters · filed 2020-10-29 | $6.34M derived: sum of 4 quarters · filed 2020-10-29 | ||
| 2019-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $3.24M derived: sum of 2 quarters · filed 2020-10-29 | $4.41M derived: sum of 3 quarters · filed 2020-10-29 | $5.37M 10-K · filed 2020-02-26 | ||
| 2019-09-30 | $1.59M 10-Q · filed 2020-10-29 | $2.76M derived: sum of 2 quarters · filed 2020-10-29 | $3.73M 10-Q · filed 2020-10-29 | $4.55M derived: sum of 4 quarters · filed 2020-10-29 | ||
| 2019-06-30 | $1.17M 10-Q · filed 2020-08-06 | $2.13M 10-Q · filed 2020-08-06 | $2.96M derived: sum of 3 quarters · filed 2020-08-06 | $3.65M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $964.00K 10-Q · filed 2020-05-08 | $1.79M derived: sum of 2 quarters · filed 2020-05-08 | $2.48M derived: sum of 3 quarters · filed 2020-05-08 | $3.10M derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2018-12-31 | $825.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $1.52M derived: sum of 2 quarters · filed 2020-02-26 | $2.14M derived: sum of 3 quarters · filed 2020-02-26 | $2.53M 10-K · filed 2020-02-26 | ||
| 2018-09-30 | $694.00K 10-Q · filed 2019-10-31 | $1.31M derived: sum of 2 quarters · filed 2019-10-31 | $1.70M 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | $619.00K 10-Q · filed 2019-08-01 | $1.82M 10-Q · filed 2018-08-07 | $1.01M 10-Q · filed 2019-08-01 | $2.39M 10-Q · filed 2018-08-07 | ||
| 2018-03-31 | $388.00K 10-Q · filed 2019-05-07 | |||||
| 2017-12-31 | $1.15M 10-K · filed 2020-02-26 | |||||
| 2017-06-30 | $37.00K 10-Q · filed 2018-08-07 | $75.00K 10-Q · filed 2018-08-07 |